or Try an Advanced Search...

    Technical Analysis for PRQR - ProQR Therapeutics B.V.

    Grade Last Price % Change Price Change
    C 3.67 1.94% 0.07
    PRQR closed up 1.94 percent on Wednesday, November 20, 2024, on 14 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical PRQR trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    20 DMA Resistance Bearish 1.94%
    Down 3 Days in a Row Weakness 1.94%
    Down 4 Days in a Row Weakness 1.94%
    Down 5 Days in a Row Weakness 1.94%
    Fell Below 20 DMA Bearish 0.55%
    1,2,3 Pullback Bullish Bullish Swing Setup 0.55%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.55%
    Older End-of-Day Signals for PRQR ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Resistance 2 days ago
    Fell Below Previous Day's Low 2 days ago
    Down 1% 2 days ago
    Up 2% 2 days ago
    Up 1% 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    PRQR Chart by TradingView
    Basic chart:

    Profile

    ProQR Therapeutics B.V., a biopharmaceutical company, is engaged in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. Its lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis. The company was founded in 2012 and is headquartered in Leiden, the Netherlands.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cystic Fibrosis Oligonucleotide Regulus Therapeutics Alnylam Pharmaceuticals Therapeutic Gene Modulation Genetic Disorder Treatment Of Cystic Fibrosis

    Is PRQR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 9 ProQR Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
    Nov 8 ProQR Therapeutics sees cash runway into mid-2027
    Nov 7 ProQR Announces Third Quarter 2024 Operating and Financial Results
    Oct 17 Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
    Sep 30 ProQR Therapeutics files for $300M mixed securities shelf
    Sep 10 ProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference
    Aug 10 ProQR Therapeutics Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
    Jun 23 Institutions own 25% of ProQR Therapeutics N.V. (NASDAQ:PRQR) shares but retail investors control 46% of the company
    Jun 18 ProQR Announces Presentation on its Axiomer™ RNA Editing Technology at RNA Editing Summit
    See more PRQR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.62
    52 Week Low 1.185
    Average Volume 1,720,859
    200-Day Moving Average 2.19
    50-Day Moving Average 2.82
    20-Day Moving Average 3.67
    10-Day Moving Average 3.79
    Average True Range 0.29
    RSI (14) 56.33
    ADX 38.52
    +DI 23.18
    -DI 14.47
    Chandelier Exit (Long, 3 ATRs) 3.34
    Chandelier Exit (Short, 3 ATRs) 4.03
    Upper Bollinger Bands 4.04
    Lower Bollinger Band 3.29
    Percent B (%b) 0.5
    BandWidth 20.46
    MACD Line 0.23
    MACD Signal Line 0.31
    MACD Histogram -0.0725
    Fundamentals Value
    Market Cap 297.85 Million
    Num Shares 81.2 Million
    EPS -0.51
    Price-to-Earnings (P/E) Ratio -7.20
    Price-to-Sales 36.79
    Price-to-Book 3.58
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.85
    Resistance 3 (R3) 3.83 3.76 3.82
    Resistance 2 (R2) 3.76 3.72 3.77 3.81
    Resistance 1 (R1) 3.72 3.69 3.74 3.73 3.80
    Pivot Point 3.64 3.64 3.66 3.65 3.64
    Support 1 (S1) 3.60 3.60 3.62 3.61 3.54
    Support 2 (S2) 3.53 3.57 3.53 3.53
    Support 3 (S3) 3.48 3.53 3.52
    Support 4 (S4) 3.49